Manufacturing
Showing 1–12 of 90 results
The past 25 years have seen a steady progression in business relationships between CDMOs and drug developers. The initial focus of identifying supply chain inefficiencies has advanced from controlling fixed costs and capacity fluctuations to gaining access to specific technologies, skills, and scientific expertise not possessed in-house. Our market research helps drug innovators understand the dynamic drug manufacturing environment, identify the right type of outsourcing model to best meet their organizations’ needs, and make smarter CDMO selection decisions based on hard data collected from outsourcing peers.
-
Navigating Cell Therapy Supply Chain Challenges
$4,900.00 – $9,900.00 -
Biologic Drug Product CDMO Benchmarking (7th Ed.)
$4,900.00 – $9,900.00 -
Biologic API CDMO Benchmarking (9th Ed.)
$4,900.00 – $9,900.00 -
2023 Cell Therapy CDMO Benchmarking
$4,900.00 – $9,900.00 -
Oral Dosage Forms Market Outlook (5th Ed.)
$5,650.00 – $11,300.00 -
2023 Gene Therapy CDMO Benchmarking
$6,750.00 – $13,500.00 -
The CMC Function at Emerging Pharma
$5,650.00 – $11,300.00 -
Sterile Injectable Drug Product Manufacturing Market Outlook: 2023-2028
$5,650.00 – $11,300.00 -
Cell & Gene Therapies Manufacturing Market Outlook (2nd Edition)
$5,650.00 – $11,300.00 -
Biologic Drug Product CDMO Benchmarking (6th Ed.)
$6,750.00 – $13,500.00 -
Small Molecule Drug Product CDMO Benchmarking (6th Ed.)
$6,750.00 – $13,500.00 -
Biologic API CDMO Benchmarking (8th Ed.)
$6,750.00 – $13,500.00
